Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06655701

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis: The Intersection of Muscle Loss and Pelvic Dysfunction

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Beylikduzu State Hospital · Academic / Other
Sex
Female
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

The primary aim of our study is to evaluate the presence of stress urinary incontinence in postmenopausal patients with and without osteoporosis, determine its impact on quality of life, and explore its relationship with sarcopenia.

Detailed description

One hundred postmenopausal women, aged 50-75, who applied to the Physical Therapy and Rehabilitation outpatient clinic at Beylikdüzü State Hospital and have Dual-X-ray Absorptiometry (DXA) measurements taken within the last 6 months, including both osteoporotic and non-osteoporotic patients, will be included in the study. Sociodemographic data such as age, gender, height, weight, and BMI will be recorded. DXA results, including femoral neck and L1-L4 T-scores and BMD values, will be obtained. Patients will be asked about osteoporosis treatment, presence of fecal incontinence, constipation, and medication use. Stress urinary incontinence will be determined through a questionnaire, and its impact on quality of life will be assessed using the Incontinence Quality of Life Scale. In the second phase, sarcopenia will be evaluated according to the Asian Working Group for Sarcopenia (AWGS) criteria by assessing skeletal muscle mass (via bioelectrical impedance analysis), handgrip strength, and the 5-times sit-to-stand test.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNo interventionNo intervention

Timeline

Start date
2024-11-15
Primary completion
2025-01-15
Completion
2025-01-15
First posted
2024-10-23
Last updated
2024-12-12

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06655701. Inclusion in this directory is not an endorsement.